Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: High Dose Nimodipine Treatment Adjunct - 1 [Phase 2]

View source ↗

Summary

This document reports an update on a Phase 2 trial of high-dose nimodipine as an adjunct treatment for cocaine-related disorders. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nimodipine (Nimodipine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 2 | Status: COMPLETED